Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids

Abstract Endogenous peptides that represent biological and pathological information of disease have attracted interest for diagnosis. However, the extraction of those low abundance peptides is still a challenge because of the complexity of human bodily fluids (HBF). Hepcidin, a peptide hormone, has...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine 2014-07, Vol.10 (5), p.e879-e888
Main Authors: Fan, Jia, PhD, Niu, Shiwen, MD, Dong, Ailian, MD, Shi, Jian, MSc, Wu, Hung-Jen, PhD, Fine, Daniel H., PhD, Tian, Yaping, PhD, Zhou, Chunxi, PhD, Liu, Xuewu, PhD, Sun, Tong, MSc, Anderson, Gregory J., PhD, Ferrari, Mauro, PhD, Nie, Guangjun, PhD, Hu, Ye, PhD, Zhao, Yuliang, PhD
Format: Article
Language:English
Subjects:
Biomarker discovery
Biomarkers - analysis
Body Fluids - chemistry
Hepcidin
Hepcidins - analysis
Humans
Internal Medicine
MALDI-TOF MS
Membranes, Artificial
Nanopores
Nanoporous silica film
Peptide
Peptides - chemistry
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Endogenous peptides that represent biological and pathological information of disease have attracted interest for diagnosis. However, the extraction of those low abundance peptides is still a challenge because of the complexity of human bodily fluids (HBF). Hepcidin, a peptide hormone, has been recognized as a biomarker for iron-related diseases. There is no rapid and reliable way to enrich them from HBF. Here we describe a peptide extraction approach based on nanoporous silica thin films to successfully detect hepcidin from HBF. Cooperative functions of nanopore to biomolecule, including capillary adsorption, size-exclusion and electrostatic interaction, were systematically investigated to immobilize the target peptide. To promote this new approach to clinical practices, we further applied it to successfully assay the hepcidin levels in HBF provided by healthy volunteers and patients suffering from inflammation. Our finding provides a high-throughput, rapid, label-free and cost-effective detection method for capturing and quantifying low abundance peptides from HBF. From the Clinical Editor Diagnosing diseases with low concentration peptide biomarkers remains challenging. This team of authors describes a peptide extraction approach based on nanoporous silica thin films to successfully detect low concentrations of hepcidin from human body fluids collected from 119 healthy volunteers and 19 inflammation patients.
ISSN:1549-9634
1549-9642
DOI:10.1016/j.nano.2014.02.005